⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4131162 | 0.73 | — | — | |
| SCHEMBL726127 | 0.71 | — | — | |
| SCHEMBL2775660 | 0.67 | — | — | |
| SCHEMBL63852 | 0.64 | — | — | |
| SCHEMBL6305646 | 0.64 | — | — | |
| SCHEMBL11800150 | 0.62 | — | — | |
| SCHEMBL11796069 | 0.62 | — | — | |
| SCHEMBL14188760 | 0.61 | — | — | |
| SCHEMBL11801107 | 0.58 | — | — | |
| SCHEMBL9908376 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2787076-B1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENE | TOKYO METROPOLITAN INST MEDICAL SCIENCE (JP) | 2019-08-28 | — | — | EP | claimed |
| US-20170357750-A1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENE | TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE (JP) | 2017-12-14 | — | — | US | claimed |
| EP-2787076-A1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND SUSCEPTIBILITY TO DISEASES BY ANALYZING GENE FOR PROTEIN CAPABLE OF BINDING TO CYCLIC-AMP-RESPONSIVE SEQUENCE | Tokyo Metropolitan Institute of Medical Science (JP) | 2014-10-08 | — | — | EP | claimed |
| US-20140243237-A1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENE | TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE (JP) | 2014-08-28 | — | — | US | claimed |
| EP-1895016-B1 | Method of evaluating drug sensitivity by analyzing GIRK channel genes | TOKYO METROPOLITAN ORG MED RES (JP) | 2010-07-14 | — | — | EP | claimed |
| US-20090092972-A1 | evaluating drug sensitivity or disease vulnerability, includes linking a gene polymorphism in a G-protein-activated inwardly rectifying K+ (GIRK) channel gene; determining if a human subject has an increased need for a narcotic analgesic to mitigate pain | TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH | 2009-04-09 | — | — | US | claimed |
| EP-1895016-A1 | Method of evaluating drug sensitivity by analyzing GIRK channel genes | Tokyo Metropolitan Organization for Medical Research (JP) | 2008-03-05 | — | — | EP | claimed |
| US-4986928-A | CLEANING COMPOUNDS, REFRIGERANTS, AEROSOL PROPELLANTS, BLOWING AGENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-22 | — | — | US | claimed |
| EP-2787076-B1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENE | TOKYO METROPOLITAN INST MEDICAL SCIENCE (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-10020406-B2 | Protective film for solar cell and solar cell comprising the same | LG CHEM, LTD. (KR) | 2018-07-10 | — | — | US | disclosed |
| EP-2711179-B1 | PROTECTION FILM FOR SOLAR CELL APPLICATION AND SOLAR CELL HAVING SAME | LG CHEMICAL LTD (KR) | 2018-07-04 | — | — | EP | disclosed |
| US-20170357750-A1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENE | TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE (JP) | 2017-12-14 | — | — | US | disclosed |
| US-9727691-B2 | Method for evaluating drug sensitivity and disease vulnerability by analyzing cyclic AMP responsive element binding protein gene | TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE | 2017-08-08 | — | — | US | disclosed |
| EP-2787076-A1 | METHOD FOR EVALUATING DRUG SENSITIVITY AND SUSCEPTIBILITY TO DISEASES BY ANALYZING GENE FOR PROTEIN CAPABLE OF BINDING TO CYCLIC-AMP-RESPONSIVE SEQUENCE | Tokyo Metropolitan Institute of Medical Science (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-4986928-A | CLEANING COMPOUNDS, REFRIGERANTS, AEROSOL PROPELLANTS, BLOWING AGENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-22 | — | — | US | disclosed |
| US-4625011-A | Neutralization of alkali metal catalysts in organopolysiloxanes | DOW CORNING CORPORATION (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0129318-A1 | Neutralization of alkali metal catalysts in organopolysiloxanes | DOW CORNING CORPORATION (US) | 1984-12-27 | — | — | EP | disclosed |
| US-4267297-A | CONTAINING ALKOXYLATED SILOXANES, ALKOXYSILANES AND AMINOALKOXYSILANES | TORAY SILICONE COMPANY, LTD. (JP) | 1981-05-12 | — | — | US | disclosed |
| US-3954893-A | INHALATION ANESTHETICS | W. R. GRACE & CO. (US) | 1976-05-04 | — | — | US | disclosed |
| US-3870797-A | Anesthetic halogenated cyclobutanes | W. R. GRACE & CO.-CONN. | 1975-03-11 | — | — | US | disclosed |